The fusion breakthrough could mean carbon-free power, but not soon. And it’s not going to be like ‘Mr. Fusion’ from ‘Back to the Future II.’
Author: Elizabeth Weise and Karen Weintraub, USA TODAY
Omicron is spreading ‘every place at once,’ experts say. What it could mean for holiday plans.
A group of Massachusetts-based researchers say they believe omicron could already account for about 15% of COVID-19 cases in some parts of the U.S.
FDA panel recommends Pfizer-BioNTech COVID-19 booster shots only for people 65 and older or at high risk
There isn’t yet sufficient evidence to support boosters for people under 65, the FDA Vaccines and Related Biological Products Advisory Committee said.
Moderna says its COVID-19 vaccine found to be 100% effective in children 12 to 17 two weeks after second dose
The Moderna vaccine was 93% effective against COVID-19 in teenagers aged 12 to 17 after the first dose and 100% two weeks after the second dose.
The coronavirus variant that first appeared in India is in the US. Here’s what to know.
Experts say it likely will not cause great harm in the U.S. because of high vaccination rates and our health care system, but they are watching it.
Pause on Johnson & Johnson COVID vaccine in US lifted by FDA, use to resume
The pause on the one-dose J&J COVID vaccine will be lifted and distribution will resume in the U.S., FDA officials said Friday night.
Amid a chaotic COVID-19 vaccine rollout, states find ways to connect shots with arms
Under a decentralized national health care system and a chaotic COVID-19 vaccine rollout, states find their own ways to reach and vaccinate residents.
CDC-convened committee votes to add nursing home residents to first phase of COVID-19 vaccine access
Everyone in Phase 1a should be able to get the first of the two-shot COVID-19 vaccine series within three weeks of one being authorized by the FDA.
Johnson & Johnson pauses COVID-19 vaccine trial due to unexplained illness — the second US trial now on hold
The Phase 3 clinical trial was temporarily halted Monday because of an unexplained illness in one of the participants, Johnson & Johnson said.